Literature DB >> 11908224

Myasthenia gravis.

Angela Vincent1, Daniel B Drachman.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11908224

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  14 in total

Review 1.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

Review 2.  Autoantigens in systemic autoimmunity: critical partner in pathogenesis.

Authors:  A Rosen; L Casciola-Rosen
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

3.  Granzyme B: evidence for a role in the origin of myasthenia gravis.

Authors:  L Casciola-Rosen; A Miagkov; K Nagaraju; F Askin; L Jacobson; A Rosen; D B Drachman
Journal:  J Neuroimmunol       Date:  2008-08-03       Impact factor: 3.478

Review 4.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

5.  Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis.

Authors:  Daniel B Drachman; Robert N Adams; Rong Hu; Richard J Jones; Robert A Brodsky
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 6.  Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells.

Authors:  Lorise C Gahring; Scott W Rogers
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

7.  C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis.

Authors:  Huibin Qi; Erdem Tüzün; Windy Allman; Shamsher S Saini; Zurina R Penabad; Silvia Pierangeli; Premkumar Christadoss
Journal:  J Neuroimmunol       Date:  2008-05-01       Impact factor: 3.478

Review 8.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

9.  Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Authors:  Natalie Kim; Amy L Stiegler; Thomas O Cameron; Peter T Hallock; Andrea M Gomez; Julie H Huang; Stevan R Hubbard; Michael L Dustin; Steven J Burden
Journal:  Cell       Date:  2008-10-09       Impact factor: 41.582

10.  Bedside testing for myasthenia gravis: the ice-test.

Authors:  J Browning; M Wallace; J Chana; J Booth
Journal:  BMJ Case Rep       Date:  2010-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.